H Died in Health Professions & Programs Subcommittee
Email me when HB 877 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 877. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill defines active pharmaceutical ingredients (APIs) and sets detailed requirements for pharmacies and other entities that sell, transfer, or distribute compounded drugs using those ingredients. It mandates compliance with USP/NF monographs or FDA‑approved lists, certification, testing, and recent FDA inspection of the manufacturing facility, plus record‑keeping and board inspections. Violations would incur a $1,000 fine per dose and possible license revocation.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 877
3 free questions a day, no accountHistory
- Died in Health Professions & Programs Subcommittee
- 1st Reading (Original Filed Version)
- Referred to Health Professions & Programs Subcommittee
- Referred to Health Care Budget Subcommittee
- Referred to Health & Human Services Committee
- Now in Health Professions & Programs Subcommittee
- Filed
Sponsors
- Koster · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 877 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 877 freeOr ask your AI assistant about HB 877 directly:
Add to Claude, ChatGPT or Cursor